ALTuCELL
PrivateCompany Overview
ALTuCELL is a biotechnology company that provides molecular and regenerative therapy for the treatment of Diabetes and other autoimmune and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
microencapsulationcell therapycell encapsulationcellular deliverybiotechnologyimmune rejectionimmunosuppressionbio-encapsulationdrug delivery platformSertoli cell therapybiotech licensingregenerative medicineclinical-stage biotechtype 1 diabetesIP licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALTuCELL Comparables
Compare ALTuCELL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Encellin | 84% | |
| Allarta Life Science | 84% | |
| PharmaCyte Biotech, Inc. | 82% | |
ALTuCELL Funding Rounds
Historical fundraising activity
ALTuCELL Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ALTuCELL's valuation, stock price, and market status.
See something wrong or outdated?